Evaluation of long-term pulmonary functions after COVID-19 infection in children: a longitudinal observational cohort study

被引:0
作者
Korkmaz, Muhammet F. [1 ]
Senkan, Gulsum E. [1 ]
Bozdemir, Sefika Elmas [2 ]
Korkmaz, Merve [3 ]
Koc, Ibrahim [4 ]
Oral, Behiye [5 ]
机构
[1] Univ Hlth Sci, City Training & Res Hosp, Bursa Fac Med, Dept Pediat, Gumus Ave 10, TR-16110 Bursa, Turkiye
[2] Univ Hlth Sci, City Training & Res Hosp, Bursa Fac Med, Dept Pediat Infect Dis, Bursa, Turkiye
[3] Uludag Univ, Fac Med, Dept Pediat Pulmonol, Bursa, Turkiye
[4] Univ Hlth Sci, City Training & Res Hosp, Bursa Fac Med, Dept Pulmonol, Bursa, Turkiye
[5] Univ Hlth Sci, City Training & Res Hosp, Bursa Fac Med, Dept Radiol, Bursa, Turkiye
来源
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES | 2024年 / 18卷 / 12期
关键词
COVID-19; long-COVID; children; pulmonary function; spirometry;
D O I
10.3855/jidc.20123
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Introduction: We aimed to present the changes that may occur in pulmonary functions in children who experienced more severe coronavirus disease 2019 (COVID-19) during long-term follow-up. Methodology: A prospective longitudinal observational cohort study was conducted with 34 pediatric patients (7-18 years) who were hospitalized with COVID-19 infection (moderate n = 25, severe n = 9), and followed up at our Pediatric Infection Outpatient Clinic for approximately two years. Pulmonary function tests (PFTs) were performed using spirometry. Results: Data from the hospitalization period revealed no significant differences between the severity groups in terms of demographic, clinical, laboratory, radiological, treatment, and outcome (p > 0.05). The median time interval between COVID-19 infection and PFTs was 15 months (range 11-29 months), and there was no significant difference between severity groups (p = 0.878). Eight patients (24%) had abnormal pulmonary functions; among them, seven had an obstructive pattern (21%) and one had a restrictive pattern (3%). The severity groups had no statistical difference in pulmonary functions (p = 0.105). While forced expiratory volume in 1 second (FEV1) %, FEV1/forced vital capacity (FVC)%, and forced expiratory flow during the middle half of FVC (FEF25-75%) ratios were lower in the severe patient group, Z-scores were similar. Among the patients continuing polyclinic follow-up, 41% had persistent respiratory symptoms before PFTs. No differences were observed in PFTs when compared based on the presence of symptoms (p > 0.05). Conclusions: We observed no significant long-term differences in pulmonary function between moderate and severe COVID-19 cases in children.
引用
收藏
页码:S267 / S274
页数:8
相关论文
共 28 条
[21]   COVID-19 in children and altered inflammatory responses [J].
Molloy, Eleanor J. ;
Bearer, Cynthia F. .
PEDIATRIC RESEARCH, 2020, 88 (03) :340-341
[22]  
NICE, 2014, OSTEOARTHRITIS CARE
[23]   Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC Global follow-up protocol: a prospective cohort study [J].
Osmanov, Ismail M. ;
Spiridonova, Ekaterina ;
Bobkova, Polina ;
Gamirova, Aysylu ;
Shikhaleva, Anastasia ;
Andreeva, Margarita ;
Blyuss, Oleg ;
El-Taravi, Yasmin ;
DunnGalvin, Audrey ;
Comberiati, Pasquale ;
Peroni, Diego G. ;
Apfelbacher, Christian ;
Genuneit, Jon ;
Mazankova, Lyudmila ;
Miroshina, Alexandra ;
Chistyakova, Evgeniya ;
Samitova, Elmira ;
Borzakova, Svetlana ;
Bondarenko, Elena ;
Korsunskiy, Anatoliy A. ;
Konova, Irina ;
Hanson, Sarah Wulf ;
Carson, Gail ;
Sigfrid, Louise ;
Scott, Janet T. ;
Greenhawt, Matthew ;
Whittaker, Elizabeth A. ;
Garralda, Elena ;
Swann, Olivia, V ;
Buonsenso, Danilo ;
Nicholls, Dasha E. ;
Simpson, Frances ;
Jones, Christina ;
Semple, Malcolm G. ;
Warner, John O. ;
Vos, Theo ;
Olliaro, Piero ;
Munblit, Daniel .
EUROPEAN RESPIRATORY JOURNAL, 2022, 59 (02)
[24]   Pulmonary function tests in the follow-up of children with COVID-19 [J].
Ozturk, Gokcen Kartal ;
Beken, Burcin ;
Dogan, Sumeyra ;
Akar, Himmet Haluk .
EUROPEAN JOURNAL OF PEDIATRICS, 2022, 181 (07) :2839-2847
[25]   Upper airway involvement in pediatric COVID-19 [J].
Parisi, Giuseppe Fabio ;
Brindisi, Giulia ;
Indolfi, Cristiana ;
Diaferio, Lucia ;
Marchese, Giuseppe ;
Ghiglioni, Daniele G. ;
Zicari, Anna Maria ;
Miraglia del Giudice, Michele .
PEDIATRIC ALLERGY AND IMMUNOLOGY, 2020, 31 :85-88
[26]   Prevalence and clinical presentation of long COVID in children: a systematic review [J].
Pellegrino, Roberta ;
Chiappini, Elena ;
Licari, Amelia ;
Galli, Luisa ;
Marseglia, Gian Luigi .
EUROPEAN JOURNAL OF PEDIATRICS, 2022, 181 (12) :3995-4009
[27]   Comparison of Persistent Symptoms After COVID-19 and Other Non-SARS-CoV-2 Infections in Children [J].
Roge, Ieva ;
Smane, Liene ;
Kivite-Urtane, Anda ;
Pucuka, Zanda ;
Racko, Iveta ;
Klavina, Lizete ;
Pavare, Jana .
FRONTIERS IN PEDIATRICS, 2021, 9
[28]   Novel therapies for growth disorders [J].
Galetaki, Despoina M. ;
Merchant, Nadia ;
Dauber, Andrew .
EUROPEAN JOURNAL OF PEDIATRICS, 2024, 183 (03) :1121-1128